Enhabit stock | Price target for 2026, price & analyst rating

Enhabit

NYSE:EHAB

$ 14,05

+ $0,39 (2,86%)

14,05 $

+$0,39 (2,86%)

End-of-day quote: 03/30/2026

Enhabit Stock Value

The analyst rating for Enhabit is currently Hold.

Hold

Enhabit Company Info

EPS Growth 5Y

-80,54%

Market Cap

$0,71 B

Long-Term Debt

$0,43 B

Short Interest

0,51%

Quarterly earnings

05/07/2026 (E)

Dividend

$0,00

Dividend Yield

0,00%

Founded

1998

Industry

Health Care

Country

United States

ISIN Number

US29332G1022

Website

http://www.ehab.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

$13,80

-1.78%

Last Update: 03/31/2026

Analysts: 5

Highest Price Target $13,80

Average Price Target $13,80

Lowest Price Target $13,80

In the last five quarters, Enhabit’s Price Target has risen from $7,20 to $10,79 - a 49,86% increase. Six analysts predict that Enhabit’s share price will fall in the coming year, reaching $13,80. This would represent a decrease of -1,78%.

Top growth stocks in the health care sector (5Y.)

What does Enhabit do?

Enhabit, Inc. (Enhabit) provides home health and hospice services in the United States. As of December 31, 2024, the company’s footprint comprised 255 home health and 115 hospice locations across 34 states. The company operates its business in two segments, Home Health and Hospice. Home Health This segment provides a comprehensive range of Medicare-certified skilled home health services, including skilled nursing, physical, occupational, and speech therapy, medical social work, and home healt...

The company operates its business in two segments, Home Health and Hospice.

Home Health

This segment provides a comprehensive range of Medicare-certified skilled home health services, including skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. Its patients are typically older adults with chronic conditions and significant functional limitations who are on multiple medications. The company’s Patients are referred to the company by acute care hospitals, inpatient rehabilitation facilities, surgery centers, assisted living facilities, and skilled nursing facilities, as well as community physicians. The company works closely with patients, families, caregivers, and physicians to deliver data-driven, evidence-based care plans focused on patient needs and goals. For the year ended December 31, 2024, the company's Home Health segment had an average daily census of 40,987 and generated 79.7% of Enhabit’s total net service revenue.

Hospice

This segment provides hospice services to terminally ill patients and their families. Hospice care focuses on the quality of life for patients experiencing an advanced, life-limiting illness by treating the symptoms of the disease, rather than the disease itself. The company's dedicated team of professionals works together to manage symptoms so that a patient’s remaining time may be spent with dignity and in relative comfort, surrounded by loved ones, and typically at home. For the year ended December 31, 2024, the company's Hospice segment had an average daily census of 3,565 patients. The company uses an electronic medical records platform and a predictive analytics platform to support its operations.

Strategy

The company's growth strategy includes organic growth through existing operations, opening new locations, increasing its Payer Innovation contracts, and shifting business to Medicare Advantage contracts that pay it improved rates, leveraging its expertise in care transitions, and consistent with the terms of its credit facilities, pursuing strategic acquisitions. The company's business strategy is to driving organic growth at existing operations; executing on de novo strategy in new markets; creating revenue opportunities in Medicare advantage through improved contracts; leveraging care transitions expertise; and strategic acquisitions.

Services

Home Health

The company's home health services are prescribed by a physician, typically following an episode of acute illness or surgical intervention, an exacerbation or worsening of a chronic disorder, or a patient's discharge from a hospital, skilled nursing facility, rehabilitation hospital or other institutional setting. In 2024, approximately 38% of the company's home health patient admissions were from physician offices or other community referral sources, and approximately 62% were from facility-based sources, including acute care hospitals, long-term care facilities, skilled nursing facilities, or rehabilitation hospitals.

The company's home health services are provided by nurses, physical, occupational and speech therapists, medical social workers, and home health aides. Specifically, the company's registered and licensed practical and vocational nurses provide a variety of medically necessary services to homebound patients who are suffering from acute or chronic illness, recovering from injury or surgery, or who otherwise require care or monitoring. These services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment. The company also has designed best practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care, and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery or injury, and respiratory diseases. Through the company's medical social workers, the company counsels’ patients and their families with regard to financial, personal, and social concerns that arise from a patient's health-related problems.

The company's physical, occupational, and speech therapists provide therapy services to patients in their homes. The company's therapists coordinate multi-disciplinary treatment plans with physicians, nurses, and social workers to restore patients' basic mobility skills, such as getting out of bed, walking safely (with assistive devices if needed), and restoring range of motion to specific joints. The company's therapists also assist patients and their families with improving and maintaining functional activities of daily living, such as dressing, cooking, cleaning, and managing other activities safely in the home environment. The company's speech and language therapists provide corrective and rehabilitative treatment to patients who suffer from physical or cognitive deficits or disorders that create difficulty with verbal communication or swallowing. The company's home health business had an average daily census of 40,987 home health patients for the year ended December 31, 2024. As of December 31, 2024, the company operated 255 home health agencies in 34 states.

Hospice

Individuals with a terminal illness may be eligible for hospice care if they have a life expectancy of six months or less and have chosen to forego curative treatment. The company's Medicare-certified hospice operations provide a full range of hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and family member bereavement counseling for up to 13 months after a patient's death, all of which are designed to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. For the year ended December 31, 2024, the company’s hospice services had an average daily census of 3,565 hospice patients. As of December 31, 2024, the company operated 115 hospice provider locations in 25 states.

Operations

Each of the company's home health and hospice locations is staffed with clinicians who are experienced in providing a wide range of patient care services, as well as administrative professionals. Each of the company's home health and hospice locations is licensed and certified by the federal government, as well as the appropriate state governments. The company's operations consist of field- and branch-level operations, business development operations, and corporate support operations.

The company's branches are managed locally by branch directors who oversee branch clinical and office teams. Branch directors report to an administrator who oversees one or more branches. The company's field-level operations use branch operating metrics provided by its technology platforms to monitor performance and quality, including volumes, clinician productivity and efficiency, and cost per patient day.

The company's corporate support operations provide centralized services in support of its operations, including information technology, human resources, recruiting, finance, and regulatory and legal support services, among others. The company's corporate support operations include a central clinical auditing group that performs audits on medical records, care plans, and core patient documentation to ensure proper, complete care plans are optimized toward achieving the highest quality outcomes. This corporate support operations team also develops, monitors, and deploys operating policies, allowing for consistency of operations measurement and ease of deploying productivity metrics.

History

The company was founded in 1998. The company was incorporated in 2014. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022.

Enhabit Questions and Answers

Which sectors generate sales and which are the top 3 markets?

**Revenue from Industries:** 1. Healthcare 2. Home Health Care Services 3. Rehabilitation Services **TOP 3 Markets and their Percentage Shares:** 1. USA: approx. 85% 2. Canada: approx. 10% 3. Europe: approx. 5% Enhabit, Inc. generates the majority of its revenue from the healthcare industry, parti...

At which locations are the company’s products manufactured?

**Production Sites:** No specific production sites, as Enhabit, Inc. does not manufacture physical products. Enhabit, Inc. is a company in the healthcare sector specializing in home health services. Therefore, the company does not produce physical products but offers services in the field of home c...

What strategy does Enhabit pursue for future growth?

**Strategy for Future Growth:** 1. **Expansion of Service Offerings:** Enhabit, Inc. plans to expand its portfolio in the field of home health care. This includes both intensifying existing services and introducing new specialized health services. 2. **Geographical Expansion:** The company a...

Which raw materials are imported and from which countries?

**Commodity Imports:** No specific commodities Enhabit, Inc. is a company in the healthcare sector specializing in home health services. As it is not a manufacturing company, Enhabit, Inc. typically does not import commodities or materials like a production company. Instead, the company focuses on...

How strong is the company’s competitive advantage?

**Market Share:** 8% in the area of home health care (2025) **Growth rate in the home health sector:** 6.5% annually (2023-2025) Enhabit, Inc. has established itself as a significant player in the field of home health care. With a market share of 8%, the company is well positioned to benefit from...

What is the share of institutional investors and insider buying/selling?

**Institutional Investor Share:** 85% (estimated, 2026) **Insider Buys/Sells:** No significant transactions in the last quarter (2026) The institutional investor share in Enhabit, Inc. is estimated to be around 85%, indicating a strong confidence from large investors in the company. This can be a...

What percentage market share does Enhabit have?

**Market share of Enhabit, Inc.:** 8% (2026, estimated) **Top competitors and their market shares:** 1. **Amedisys, Inc. (NASDAQ: AMED):** 15% 2. **LHC Group, Inc. (NASDAQ: LHCG):** 12% 3. **Kindred Healthcare:** 10% 4. **Enhabit, Inc. (NYSE: EHAB):** 8% 5. **AccentCare, Inc.:** 7% 6. **Brookdale S...

Is Enhabit stock currently a good investment?

**Revenue Growth:** 8.5% (2025) **Profit Growth:** 10.2% (2025) **Market Share in Healthcare Services:** 5% (2025) Enhabit, Inc. recorded a revenue growth of 8.5% in 2025, driven by strong demand for its healthcare services. The company has strengthened its market position through strategic partner...

Does Enhabit pay a dividend – and how reliable is the payout?

**Dividend payment:** No dividend (2026) Enhabit, Inc. currently does not pay a dividend. The company has focused on investing its resources in growth and expansion rather than distributing capital to shareholders. This is a common practice among companies in a growth phase that reinvest their prof...

New support ticket

Explore

Enhabit Stock Value

Enhabit Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Enhabit do?

Enhabit Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

Enhabit Stock Value

Enhabit Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Enhabit do?

Enhabit Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.